EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive Multi-Omics Analysis Identifies Lactylation-Related Gene RAN as a Novel Prognostic Biomarker and Therapeutic Target in Glioma

Shunda Wang, Fan Tang, Hong Chen, Jingyue Pang, Ying Zhang, Jianjing Yang, Yue Zhang

Frontiers in Bioscience-Landmark · 2025

DOI: 10.31083/fbl46765 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Shunda Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, 325000 Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Glioma, Biomarkers, Tumor, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang Province Health Industry Science and Technology Plan General Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gliomas are the most aggressive primary malignancies of the central nervous system (CNS) and exhibit marked heterogeneity that is closely associated with metabolic reprogramming. Emerging evidence underscores the pivotal role of lactylation modifications in shaping the tumor microenvironment (TME) and facilitating glioma progression. This study aimed to systematically identify key lactylation-related genes (LRGs), elucidate their functional roles and associated pathways, and explore their potential as novel therapeutic targets using multi-omics data.

Methods

We combined various datasets from the TCGA, GEO, and CGGA databases, including RNA-seq, single-cell RNA sequencing (scRNA-seq), and spatial transcriptomics. Key LRGs were identified through a multi-step analytical pipeline that involved processing scRNA-seq data using (Seurat, scoring), cell-type-specific lactylation scoring (AUCell), high-dimensional weighted gene co-expression network analysis (hdWGCNA) and applying rigorous machine learning-based feature selection utilizing 10 algorithms and 101 combinatorial strategies. We comprehensively assessed the prognostic value associated with the immune microenvironment, and spatiotemporal heterogeneity of the prioritized RAN. Functional validation was executed using shRNA-mediated knockdown in glioma cell lines, including LN229, U87, and U251, while evaluating proliferation (CCK-8, colony formation, EdU), migration (wound healing), invasion (Transwell), and pathway activity (using western blot). Results: scRNA-seq analysis revealed distinct lactylation enrichment patterns across glioma cell types, with malignant cells exhibiting the highest scores. hdWGCNA identified a gene module (royal blue) strongly correlated with lactylation activity (correlation = 0.75). The intersection of this module with a curated set of LRGs yielded 22 candidate genes. Subsequent machine learning analysis using (ENet, α = 0.4) prioritized six core LRGs (PDAP1, ALYREF, CBX3, MAGOH, RAN, TMSB4X). RAN, an understudied gene in glioma, was selected for further investigation. High RAN expression correlated significantly with poor patient prognosis, reduced immune cell infiltration (assessed by ESTIMATE, CIBERSORT, xCell, ssGSEA), and distinct spatiotemporal heterogeneity within tumors (analyzed using spatial transcriptomics, Monocle2). Glioma cell invasion, migration, colony formation, and proliferation were all markedly inhibited by RAN knockdown. Mechanistically, reduced p-AKT levels following knockdown and functional rescue with a PI3K/AKT activator (SC79) indicate that RAN increased these malignant traits by activating the PI3K/AKT signaling pathway.

Conclusion

Our study established lactylation modifications as a crucial regulator of the TME and glioma progression. Through integrative multi-omics analysis and robust machine learning techniques, we determined that RAN was a novel lactylation-associated gene. RAN is a potent, independent prognostic biomarker that promotes glioma malignancy via the PI3K/AKT pathway. Our results demonstrate RAN as a prospective therapeutic target and establish a novel framework for individualized therapy for glioma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBiomarkers, TumorBrain NeoplasmsHumansPrognosisTumor MicroenvironmentGene Expression Regulation, NeoplasticMultiomicsCell Line, TumorSpatial Transcriptomics

Stichwörter der Autor:innen

gliomalactylationmachine learningtumor microenvironment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, 325000 Wenzhou, Zhejiang, China.
  • Zhejiang-US Joint Laboratory for Aging and Neurological Disease Research, The First Affiliated Hospital of Wenzhou Medical University, 325000 Wenzhou, Zhejiang, China.
  • Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, The First Affiliated Hospital of Wenzhou Medical University, 325000 Wenzhou, Zhejiang, China.
  • Department of Otolaryngology, Wenzhou People's Hospital, 325000 Wenzhou, Zhejiang, China.

Förderung

  • National Natural Science Foundation of China
  • Zhejiang Province Health Industry Science and Technology Plan General Project

Zitieren

APA

Wang, S., Tang, F., Chen, H., Pang, J., Zhang, Y., Yang, J., & Zhang, Y. (2025). Comprehensive Multi-Omics Analysis Identifies Lactylation-Related Gene RAN as a Novel Prognostic Biomarker and Therapeutic Target in Glioma. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl46765

Vancouver

Wang S, Tang F, Chen H, Pang J, Zhang Y, Yang J, et al. Comprehensive Multi-Omics Analysis Identifies Lactylation-Related Gene RAN as a Novel Prognostic Biomarker and Therapeutic Target in Glioma. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl46765

BibTeX
@article{Wang2025,
  author = {Wang, Shunda and Tang, Fan and Chen, Hong and Pang, Jingyue and Zhang, Ying and Yang, Jianjing and Zhang, Yue},
  title = {Comprehensive Multi-Omics Analysis Identifies Lactylation-Related Gene RAN as a Novel Prognostic Biomarker and Therapeutic Target in Glioma},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2025},
  doi = {10.31083/fbl46765}
}
Kostenlos starten →